Nothing was found on your request

CNBC: Business

Starbucks announces trials for recyclable and compostable cups

Starbucks announced its plan to start testing recyclable and compostable cups in several markets later this year at its annual shareholders meeting.

Here's how Starbucks is planning for its future

At its annual shareholders meeting Wednesday, Starbucks shared two targets to aid in future growth: start-ups and the in-store experience.

Ford tweaks Tesla on Twitter as Detroit carmaker plans 'Mustang-inspired' all-electric SUV

President of the Americas Joe Hinrichs told CNBC the company is moving quickly toward producing what it previously described as a "Mustang-inspired" all-electric SUV that will be in showrooms next

General Mills stock jumps after earnings beat and raised outlook

Shares of General Mills jumped 4 percent during premarket trading Wednesday after the company reported earnings.

Cockpit voice recorder of doomed Lion Air jet depicts pilots' frantic search for a fix

The pilots of a doomed Lion Air Boeing 737 Max scoured a handbook as they struggled to understand why the jet was lurching downwards, but ran out of time before it hit the water.

Google is winning in education, but Apple and Microsoft are battling for market share

Google has a majority of the U.S. education tech market, largely because Chromebooks are affordable.

Sterling slips after UK Prime Minister Theresa May requests three-month delay to Brexit

Any delay would need to be accepted by all 27 EU member states. May is set to travel to Brussels on Thursday to discuss the options.

Start-up behind erectile dysfunction website Roman launches health service for women

Ro, the men's health start-up known for straight-to-your-door erectile dysfunction medication, is launching a new service targeting women.

Pfizer buys stake in French gene therapy firm Vivet

Pfizer Inc said on Wednesday it has acquired a 15 percent stake in Vivet Therapeutics, and has an exclusive option to fully acquire the privately held French company that develops gene therapies for

Autos and miners drag European markets lower; Bayer shares tumble 12%; Sterling slips

European stocks were lower Wednesday morning, as investors awaited a policy decision by the U.S. Federal Reserve.

A day before it crashed, Lion Air's Boeing plane was reportedly saved by an off-duty pilot

An off-duty pilot correctly identified the problem the crew was facing and guided them to disable the flight control system in order to save the plane, Bloomberg reported.

Cramer Remix: You can't invest in Kylie Jenner, but this stock could help

Jim Cramer reveals how Ulta Beauty is profiting off of its partnership with the billionaire mogul and how it could benefit your portfolio.

One of the stock market's highest flyers is aiming to make more money from its priciest acquisition

Atlassian is seeking to make some money from some free users of Trello, its task-management app.

Norwegian Cruise Line CEO: Attracting millennial guests through Instagram

Jim Cramer talks with Norwegian Cruise Lines CEO Frank Del Rio about the company's plans to add more ships to its line and going after its fastest-growing customer base.

Cramer: Market action shows investors are taking a 'leap of taste'

Jim Cramer says all of the rising on the market is not justified, but investors have some breathing room.

Sage Therapeutics stock rises after FDA approves first postpartum depression drug Zulresso

Zulresso is an IV injection used to treat the sometimes life-threatening condition of postpartum depression, which is a major depressive episode that occurs following or leading up to childbirth.

US jury rules against Bayer in Roundup cancer case

A U.S. jury on Tuesday found Bayer AG's glyphosate-based weed killer to be a "substantial factor" in causing a man's non-Hodgkin's lymphoma, allowing the trial to proceed into a second phase on

Investors are rushing to capitalize on apps that help stressed workers meditate and sleep

Meditation and sleep apps have raised hundreds of millions of dollars in venture capital, hinting at the start of a new lifestyle business.

China's GoPro rival plans IPO in 2020 after raising fresh round of funding

Insta360 sells cameras that are able to film 360-degree video. The company raised $30 million and its CEO, JK Liu, told CNBC that it is now looking ahead to an initial public offering in 2020.